Zusammenfassung
Der Begriff Insulinresistenz beschreibt den klinischen Zustand einer herabgesetzten Insulinwirkung auf die Glukosehomöostase. Die Insulinresistenz ist ein etablierter Risikofaktor für die Entwicklung von gestörter Glukosetoleranz und Diabetes mellitus Typ 2. Dieses Kapitel stellt die Grundlagen von Physiologie und Pathophysiologie der Insulinwirkung sowie die organsystembezogene Pathogenese der Insulinresistenz dar. Aufgrund des großen klinischen und wissenschaftlichen Interesses an der Insulinresistenz als zentralem Motiv des metabolischen Syndroms, wurden in den zurückliegenden Jahrzehnten eine Vielzahl von Methoden und Indizes zur Messung und Beschreibung des Ausmaßes der Insulinresistenz entwickelt. Im zweiten Teil des Kapitels werden daher häufig eingesetzte Methoden und Surrogatparameter beschrieben und hinsichtlich ihrer in den meisten Fällen nur eingeschränkten Einsetzbarkeit und Aussagekraft bei Patienten im Kindes- und Jugendalter diskutiert.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Bacha F, Lee S, Gungor N, Arslanian SA (2010) From pre-diabetes to type 2 diabetes in obese youth: pathophysiological characteristics along the spectrum of glucose dysregulation. Diabetes Care 33:2225–2231
Belfiore F, Iannello S, Volpicelli G (1998) Insulin sensitivity indices calculated from basal and OGTT-induced insulin, glucose, and FFA levels. Mol Genet Metab 63:134–141
Bell GI, Kayano T, Buse JB, Burant CF, Takeda J, Lin D, Fukumoto H, Seino S (1990) Molecular biology of mammalian glucose transporters. Diabetes Care 13:198–208
Boisseau N, Delamarche P (2000) Metabolic and hormonal responses to exercise in children and adolescents. Sports Med 30:405–422
Cali AM, Man CD, Cobelli C, Dziura J, Seyal A, Shaw M, Allen K, Chen S, Caprio S (2009) Primary defects in beta-cell function further exacerbated by worsening of insulin resistance mark the development of impaired glucose tolerance in obese adolescents. Diabetes Care 32:456–461
Dam V, Sikder T, Santosa S (2016) From neutrophils to macrophages: differences in regional adipose tissue depots. Obes Rev 17:1–17
Denzer C, Thiere D, Muche R, Koenig W, Mayer H, Kratzer W, Wabitsch M (2009) Gender-specific prevalences of fatty liver in obese children and adolescents: roles of body fat distribution, sex steroids, and insulin resistance. J Clin Endocrinol Metab 94:3872–3881
George L, Bacha F, Lee S, Tfayli H, Andreatta E, Arslanian S (2011) Surrogate estimates of insulin sensitivity in obese youth along the spectrum of glucose tolerance from normal to prediabetes to diabetes. J Clin Endocrinol Metab 96:2136–2145
Golan R, Shelef I, Rudich A, Gepner Y, Shemesh E, Chassidim Y, Harman-Boehm I, Henkin Y, Schwarzfuchs D, Ben Avraham S, Witkow S, Liberty IF, Tangi-Rosental O, Sarusi B, Stampfer MJ, Shai I (2012) Abdominal superficial subcutaneous fat: a putative distinct protective fat subdepot in type 2 diabetes. Diabetes Care 35:640–647
Gungor N, Bacha F, Saad R, Janosky J, Arslanian S (2005) Youth type 2 diabetes: insulin resistance, beta-cell failure, or both. Diabetes Care 28:638–644
Gutt M, Davis CL, Spitzer SB, Llabre MM, Kumar M, Czarnecki EM, Schneiderman N, Skyler JS, Marks JB (2000) Validation of the insulin sensitivity index (ISI(0,120)): comparison with other measures. Diabetes Res Clin Pract 47:177–184
Hershkop K, Besor O, Santoro N, Pierpont B, Caprio S, Weiss R (2016) Adipose insulin resistance in obese adolescents across the spectrum of glucose tolerance. J Clin Endocrinol Metab 101:2423–2431
Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward WK, Beard JC, Palmer JP (1993) Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42:1663–1672
Kelsey MM, Zeitler PS (2016) Insulin resistance of puberty. Curr Diab Rep 16:64
Körner A, Wiegand S, Hungele A, Tuschy S, Otto KP, l’Allemand-Jander D, Widhalm K, Kiess W, Holl RW, I APV, CNO German (2013) Longitudinal multicenter analysis on the course of glucose metabolism in obese children. Int J Obes 37:931–936
Levy-Marchal C, Arslanian S, Cutfield W, Sinaiko A, Druet C, Marcovecchio ML, Chiarelli F (2010) Insulin resistance in children: consensus, perspective, and future directions. J Clin Endocrinol Metab 95:5189–5198
Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462–1470
Oh YS, Bae GD, Baek DJ, Park EY, Jun HS (2018) Fatty acid-induced lipotoxicity in pancreatic beta-cells during development of type 2 diabetes. Front Endocrinol (Lausanne) 9:384
Panarotto D, Rémillard P, Bouffard L, Maheux P (2002) Insulin resistance affects the regulation of lipoprotein lipase in the postprandial period and in an adipose tissue-specific manner. Eur J Clin Investig 32:84–92
Perry RJ, Samuel VT, Petersen KF, Shulman GI (2014) The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes. Nature 510:84–91
Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI (2004) Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350:664–671
Raygor V, Abbasi F, Lazzeroni LC, Kim S, Ingelsson E, Reaven GM, Knowles JW (2019) Impact of race/ethnicity on insulin resistance and hypertriglyceridaemia. Diab Vasc Dis Res 16:153–159
Rosenfield RL, Ehrmann DA (2016) The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev 37:467–520
Samuel VT, Shulman GI (2016) The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. J Clin Invest 126:12–22
Savage DB, Petersen KF, Shulman GI (2007) Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev 87:507–520
Schwartz B, Jacobs DR, Moran A, Steinberger J, Hong CP, Sinaiko AR (2008) Measurement of insulin sensitivity in children: comparison between the euglycemic-hyperinsulinemic clamp and surrogate measures. Diabetes Care 31:783–788
Shulman GI (2000) Cellular mechanisms of insulin resistance. J Clin Invest 106:171–176
Soonthornpun S, Setasuban W, Thamprasit A, Chayanunnukul W, Rattarasarn C, Geater A (2003) Novel insulin sensitivity index derived from oral glucose tolerance test. J Clin Endocrinol Metab 88:1019–1023
Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Järvinen H, Van Haeften T, Renn W, Gerich J (2000) Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 23:295–301
Styne DM, Arslanian SA, Connor EL, Farooqi IS, Murad MH, Silverstein JH, Yanovski JA (2017) Pediatric obesity-assessment, treatment, and prevention: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 102:709–757
Unger RH (2003) Lipid overload and overflow: metabolic trauma and the metabolic syndrome. Trends Endocrinol Metab 14:398–403
Weiss R (2007) Fat distribution and storage: how much, where, and how. Eur J Endocrinol 157(Suppl 1):S39–S45
Weiss R, Dufour S, Taksali SE, Tamborlane WV, Petersen KF, Bonadonna RC, Boselli L, Barbetta G, Allen K, Rife F, Savoye M, Dziura J, Sherwin R, Shulman GI, Caprio S (2003) Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning. Lancet 362:951–957
Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M, Morrison J, Sherwin RS, Caprio S (2004) Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 350:2362–2374
Weiss R, Taksali SE, Dufour S, Yeckel CW, Papademetris X, Cline G, Tamborlane WV, Dziura J, Shulman GI, Caprio S (2005) The „obese insulin-sensitive“ adolescent: importance of adiponectin and lipid partitioning. J Clin Endocrinol Metab 90:3731–3737
Yeckel CW, Weiss R, Dziura J, Taksali SE, Dufour S, Burgert TS, Tamborlane WV, Caprio S (2004) Validation of insulin sensitivity indices from oral glucose tolerance test parameters in obese children and adolescents. J Clin Endocrinol Metab 89:1096–1101
Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y, Bergeron R, Kim JK, Cushman SW, Cooney GJ, Atcheson B, White MF, Kraegen EW, Shulman GI (2002) Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 277:50230–50236
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature
About this chapter
Cite this chapter
Denzer, C., Heinze, E. (2022). Insulinresistenz und Insulinsensitivität. In: Wabitsch, M., Hebebrand, J., Kiess, W., Reinehr, T., Wiegand, S. (eds) Adipositas bei Kindern und Jugendlichen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-59216-8_22
Download citation
DOI: https://doi.org/10.1007/978-3-662-59216-8_22
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-59215-1
Online ISBN: 978-3-662-59216-8
eBook Packages: Medicine (German Language)